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Abstract 
This chapter analyzes the quantification strategies in real-time RT-PCR and all 
corresponding  markers of a successful real-time RT-PCR. The following aspects are 
describes in detail: RNA extraction, reverse transcription (RT), and general quantification 
strategies—absolute vs. relative quantification, real-time PCR efficiency calculation, data 
evaluation, automation of quantification, data normalization, and statistical comparison. The 
discussion turns into practical considerations with focus on specificity and sensitivity. 
 
 
3.1. Introduction 
Reverse transcription (RT) followed by polymerase chain reaction (PCR) represents a 
powerful tool for the detection and quantification of mRNA. Real-time RT-PCR (or kinetic RT-
PCR) is widely and increasingly used because of its high sensitivity, good reproducibility, and 
wide dynamic quantification range.
1-4 The first practical kinetic PCR technology, the 5'-
nuclease assay, was established 1993 and combines the exponential PCR amplification of a 
specific transcript with the monitoring of newly synthesized DNA in each performed PCR 
cycle.
5-7 It is the most sensitive method for the detection and quantification of gene 
expression levels, in particular for low abundant transcripts in tissues with low RNA 
concentrations, from limited tissue sample and for the elucidation of small changes in mRNA 
expression levels.
1-4,8-12 While kinetic RT-PCR has a tremendous potential for analytical and 
quantitative applications, a comprehensive understanding of its underlying principles is 
important. Fidelity of real-time RT-PCR is associated with its "true" specificity, sensitivity, 
reproducibility, and robustness and, as a fully reliable quantitative method, it suffers from the 
problems inherent in RT and PCR, e.g., amplification of unspecific products, primer-dimers, 
amplification efficiencies, hetero-duplex formation, etc.
13  
This chapter analyzes the quantification strategies in real-time RT-PCR and all 
corresponding markers of a successful real-time RT-PCR. 
 
 
3.2.  Markers of a Successful Real-Time RT-PCR Assay 
 
3.2.1. RNA Extraction 
The integrity of purified RNA is critical to all gene expression analysis techniques. The 
preparation of intact cellular total RNA or pure mRNA is the first marker in gene 
quantification. For successful and reliable diagnostic use, real-time RT-PCR needs high-
quality, DNA-free, and undegraded RNA.
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assessment
30 of the starting RNA sample is particularly important for absolute quantification 
methods that normalize specific mRNA expression levels against total RNA ("molecules/g 
total RNA" or "concentrations/g total RNA").
28,29 RNA, especially long mRNA up to 10 kb,
14 is 
easily degraded by cleavage of RNases during tissue sampling, RNA purification, and RNA 
storage. The source of RNA, sampling techniques (biopsy material, single cell sampling, and 
laser microdissection),
2,16,17 as well as RNA isolation techniques (either total RNA or poly-
adenylated RNA) often vary significantly between processing laboratories.
15 RNA extracted 
from adipose or collagen-rich tissues often has a lower yield and is of lesser quality, and 
contains partly degraded RNA sub-fractions (own unpublished results). Particular RNA 
extraction techniques can work more effectively in one specific tissue type compared with 
another one, and result in up to 10-fold variations in total RNA yield.
15 RNA may contain 
tissue enzyme inhibitors that result in reduced RT and PCR reaction efficiencies and 
generate unreliable and "wrong" quantification results.
14,15  
Most RNA preparations are contaminated with DNA and protein at very low levels. Even 
high-quality commercially obtained RNAs contain detectable amounts of DNA.
15 While this is 
not a problem for some applications, the tremendous amplification power of kinetic PCR may 
result in even the smallest amount of DNA contamination to interfering with the desired 
"specific amplification." To confirm the absence of residual DNA either a "minus-RT" or 
"water control" should always be included in the experimental design. It may be necessary to 
treat the RNA sample with commercially available RNase-free DNase, to get rid of residual 
DNA. However, unspecific side reactions of the DNase often result in RNA degradation (own 
unpublished results). It is always necessary to remove the DNase prior to any RT or PCR 
step.  
Furthermore, the design of the PCR product should incorporate at least one exon-exon splice 
junction to allow a product obtained from the cDNA to be distinguished on electrophoresis 
from genomic DNA contamination. However, processed pseudogenes (e.g., ￿-actin, GAPDH 
or 18S rRNA) can be present and lead to confusion in data interpretation. In addition, intron-
lacking pseudogenes (e.g.￿-actin) with equal sequence length to endogenous mRNA have 
been described.
18-24 They prevent a distinction between products originating from genomic 
DNA versus mRNA, which poses a significant problem in qualitative and quantitative gene 
quantification. Therefore, various housekeeping genes must be tested or multiplex assays of 
reference genes as internal controls for the assessment of RNA and cDNA quality must be 
performed.
25-27  
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3.2.2. Reverse Transcription 
The  second marker in quantitative RT-PCR is the production of a single-stranded (ss) 
complementary DNA copy (cDNA) of the RNA through the reverse transcriptase (RT) and its 
dynamic range, sensitivity, and specificity are prime consideration for a successful kinetic 
RT-PCR assay.
31-34 For many quantitative applications, MMLV H
– RT is the enzyme of 
choice,
31,35,36 as its cDNA synthesis rate is up to 40-fold greater than that of AMV (own 
unpublished results). Newly available thermostable RNAse H
- RT maintains its activity up to 
70°C, thus permitting increased specificity and efficiency of first primer annealing. However, 
this enzyme may be less robust than more conventional ones as it appears to be more 
sensitive to inhibitors present in RNA preparation.
28,36,37  
The RT step is the source of most of the variability in a kinetic RT-PCR experiment and for 
each enzyme the specific reaction conditions has to be optimized. Salt contamination, 
alcohol, phenol, and other inhibitors carried over from the RNA isolation process can affect 
the apparent RT efficiency.
13,31,34 Another source of variability is the choice of priming method 
used to initiate cDNA synthesis, which can be either target gene-specific or non-specific. 
Target gene-specific primers work well in conjunction with elevated RT-reaction 
temperatures to eliminate spurious transcripts.
36,37 The same reverse primer is used for the 
subsequent PCR assay in conjunction with the corresponding gene-specific sense primer 
(forward primer). However, the use of gene-specific primers necessitates a separate RT 
reaction for each gene of interest. It cannot be assumed that different reactions have the 
same cDNA synthesis efficiency; the result can be high variability during multiple RT 
reactions.  
To circumvent these high inter-assay variations in RT, target gene unspecific primers, e.g., 
random hexamer, octamer or decamer primers, can be used and a cDNA pool can be 
synthesized. Similarly, poly-T oligonucleotides (consisting solely of 16-25 deoxythymidine 
residues) can anneal to the polyadenylated 3' (poly-A) tail found on most mRNAs.
13,30 cDNA 
pools synthesized with unspecific primers can be split into a number of different target-
specific kinetic PCR assays. This maximizes the number of genes that can be assayed from 
a single cDNA pool, derived from one small RNA sample. Therefore the gene expression 
results are directly comparable between the applied assays, at least within one and the same 
RT pool. In conclusion, a rank order of RT efficiency can be shown for the applied different 
primers for ONE specific gene: random hexamer primers > poly-dT primer > gene-specific 
primer (own unpublished results). 
Importantly, not only RNA quantity and quality, but also yield and quality of cDNA can be 
highly variable. Certainly, there is evidence that cDNA yield from sequences near the 5' end 
of partially degraded mRNAs is significantly less than from sequences near the poly-A tail 
and assays aimed at identifying RNA degradation are being developed.
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internal quality control of cDNA synthesis is essential. Controls are generally performed by 
PCR amplification of reference genes, mostly common housekeeping genes (GAPDH, 
albumin, actins, tubulins, cyclophilin, microglobulins, 18S ribosomal RNA (rRNA) or 28S 
rRNA).
11,27,39-43 The chosen reference genes used as well as the expression levels vary 
between different laboratories, and only few of them have been critically evaluated (see 
Section 3.4. Normalization). 
 
 
3.2.3. Comparison of Real-Time RT-PCR with Classical End-Point Detection 
Method 
The efficacy of kinetic RT-PCR is measured by its specificity, low background fluorescence, 
steep fluorescence increase, high amplification efficiency, and high level plateau.
44 Typically, 
the PCR reaction can be divided in four characteristic phases:
45 1
st phase is hidden under the 
background fluorescence where an exponential amplification is expected; 2
nd phase with 
exponential amplification that can be detected and above the background; 3
rd phase with 
linear amplification efficiency and a steep increase of fluorescence; and finally 4
th phase or 
plateau phase, defined as the attenuation in the rate of exponential product accumulation, 
which is seen concomitantly in later cycles.
46,47 The amount of amplified target is directly 
proportional to the input amount of target only during the exponential phase of PCR 
amplification. Hence the key factor in the quantitative ability of kinetic RT-PCR is that it 
measures the product of the target gene within that phase.
10,45,48-51 Since data acquisition 
and analysis are performed in one and the same tube, this increases sample throughput, 
reduces the chances of carryover contamination, and removes post-PCR processing as a 
potential source of error.
52  
In contrast, during the plateau phase of the PCR there is no direct relation of "DNA input" to 
"amplified target"; hence classical RT-PCR assays have to be stopped at least in linear 
phase.
44, 53 The exponential range of amplification has to be determined for each transcript 
empirically by amplifying equivalent amounts of cDNA over various cycles of the PCR or by 
amplifying dilutions of cDNA over the same number of PCR cycles.
10, 53 Amplified RT-PCR 
end product is later detected by ethidium bromide gel staining, radioactivity labelling, 
fluorescence labelling, high-performance liquid chromatography, southern blotting, 
densitometric analysis, or other post-amplification detection methods.
53-55 This step-wise 
accumulation of post-PCR variability
10,49, 53 leads to semi-quantitative results with high intra-
assay (around 30-40%) and inter-assay variability (around 50-70%; own unpublished results) 
in endpoint detection assays. Finally, whereas real-time methods have a dynamic range of A-Z of quantitative PCR (Editor:  SA Bustin)                                     Chapter3. Quantification strategies in real-time PCR    92 
greater than eight orders of magnitude, the dynamic range of the endpoint assays is at best 
two.
10, 49, 56  
 
 
3.2.4. Chemistry Developments for Real-Time RT-PCR 
The third marker in kinetic RT-PCR is the right detection chemistry. Two general methods for 
the quantitative detection of the amplicon have become established: gene-specific 
fluorescent probes or specific double strand (ds) DNA binding agents
8,49,52,57,58 based on 
fluorescence resonance energy transfer (FRET).
11,48,59 The best-know probe-based system is 
ABI’s TaqMan,
6,60,61 which makes use of the 5'-3' exonuclease activity of Taq polymerase to 
quantitate target sequences in the samples. Probe hydrolysis separates fluorophore and 
quencher and results in an increased fluorescence signal called "Förster type energy 
transfer."
62,63. The alternative is a non-sequence specific fluorescent intercalating dsDNA 
binding dye, e.g., SYBR Green I (Molecular Probes) or ethidium bromide.
58 For single PCR 
product reactions with well-designed primers, SYBR Green I can work extremely well, with 
spurious non-specific background only showing up in very late cycles.
4,47,56 Among the real-
time detection chemistry, SYBR Green I and TaqMan assays produced comparable dynamic 
range and sensitivity, while SYBR Green I detection was more precise and produced a more 
linear decay plot than the TaqMan probe detection.
10  
 
 
3.2.5. Real-Time RT-PCR Platforms 
A detailed description of all real-time PCR platforms is available under http://cyclers.gene-
quantification.info/  These PCR machines differ in sample capacity, up to 96-well and 384-
well standard format, others process 72 (RotorGene) or only 32 samples and require 
specialized glass capillaries (LightCycler), excitation method (lasers and others broad-
spectrum light sources with various filters), and fluorescence acquisition channels. There are 
also platform-specific differences in how the software processes data with focus on absolute 
or relative quantification strategies.
61,64,65 For at least two systems and chemistries, the ABI 
PRISM 7700 using "TayMan Probes" and Roche’s LightCycler using "Hybridization Probes," 
there is little difference in accuracy and performance.
66  
 
 
3.2.6. Quantification Strategies in Kinetic RT-PCR 
The quantification strategy is the principal marker in gene quantification. Generally, two 
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measured by absolute or relative quantitative real-time RT-PCR. Absolute quantification 
relates the PCR signal to input copy number using a calibration curve, while relative 
quantification measures the relative change in mRNA expression levels. The reliability of an 
absolute real-time RT-PCR assay depends on the condition of "identical" amplification 
efficiencies for both the native target and the calibration curve in RT reaction and in following 
kinetic PCR.
67-69 Relative quantification is easier to perform than absolute quantification 
because a calibration curve is not necessary. It is based on the expression levels of a target 
gene versus a housekeeping gene (reference or control gene) and in theory is adequate for 
most purposes to investigate physiological changes in gene expression levels.
61,64 The units 
used to express relative quantities are irrelevant, and the relative quantities can be compared 
across multiple real-time RT-PCR experiments.
1  
 
 
3.2.6.1. Absolute  Quantification 
Calibration curves are highly reproducible and allow the generation of highly specific, 
sensitive and reproducible data.
3,4,47,54,56 However, the external calibration curve model has to 
be thoroughly validated as the accuracy of absolute quantification in real-time RT-PCR 
depends entirely on the accuracy of the standards. Standard design, production, 
determination of the exact standard concentration, and stability over long storage time is not 
straightforward and can be problematic. The dynamic range of the performed calibration 
curve can be up to nine orders of magnitude from < 10
1 to > 10
10 start molecules, depending 
on the applied standard material.
4,56,71 The calibration curves used in absolute quantification 
can be based on known concentrations of DNA standard molecules, e.g., recombinant 
plasmid DNA (recDNA), genomic DNA, RT-PCR product, and commercially synthesized big 
oligonucleotide.
3,4,49,54,58,71 Stability and reproducibility in kinetic RT-PCR depends on the type 
of standard used and depends strongly on "good laboratory practice." Cloned recDNA and 
genomic DNA are very stable and generate highly reproducible standard curves even after a 
long storage time, in comparison to freshly synthesized DNA. Furthermore, the longer 
templates derived from recDNA and genomic DNA mimic the average native mRNA length of 
about 2 kb better than shorter templates derived from RT-PCR product or oligonucleotides. 
They are more resistant against unspecific cleavage and proofreading activity of polymerase 
during reaction setup and in kinetic PCR (own unpublished results). One advantage of the 
shorter templates and commercially available templates is an accurate knowledge of its 
concentration and length. A second advantage is that their use avoids the very time 
consuming process of having to produce standard material: standard synthesis, purification, 
cloning, transformation, plasmid preparation, linearization, verification, and exact 
determination of standard concentration.
4,47,49,56  A-Z of quantitative PCR (Editor:  SA Bustin)                                     Chapter3. Quantification strategies in real-time PCR    94 
A problem with DNA-based calibration curves is that they are subject to the PCR step only, 
unlike the unknown mRNA samples that must first be reverse transcribed. This increases the 
potential for variability of the RT-PCR results and the amplification results may not be strictly 
comparable with the results from the unknown samples. However, the problem of the 
sensitivity of the RT-PCR to small variations in the reaction setup is always lurking in the 
background as a potential drawback to this simple procedure. Therefore, quantification with 
external standards requires careful optimization of its precision (replicates in the same kinetic 
PCR run – intra-assay variation) and reproducibility (replicates in separate kinetic PCR runs 
– inter-assay variation) in order to understand the limitations within the given 
application.
4,54,56  
A recombinant RNA (recRNA) standard that was synthesized in vitro from a cloned RT-PCR 
fragment in plasmid DNA is one option.
4,7,47,56,72 However, identical RT efficiency, as well as 
real-time PCR amplification efficiencies for calibration curve and target cDNA must be tested 
and confirmed if the recRNA is to provide a valid standard for mRNA quantification.
4 This is 
because
 only the specific recRNA molecules are present during RT and the kinetics of cDNA 
synthesis are not like those in native RNA (the unknown sample) that also contain a high 
percentage of natural occurring subfractions, e.g., ribosomal RNA (rRNA, ~ 80%) and 
transfer RNA (tRNA, 10-15%). These missing RNA subfractions can influence the cDNA 
synthesis rate and in consequence RT efficiency rises and calibration curves are then 
overestimated in gene quantification.
36,73 To compensate for background effects and mimic a 
natural RNA distribution like in native total RNA, total RNA isolated from bacterial or insect 
cell lines can be used. Alternatively commercially available RNA sources can be used as 
RNA background, e.g., poly-A RNA or tRNA, but they do not represent a native RNA 
distribution over all RNA subspecies.
4 Earlier results suggest, that a minimum of RNA 
background is generally needed and that it enhances RT synthesis efficiency rate. Low 
concentrations of recRNA used in calibration curves should always be buffered with 
background or carrier RNA; otherwise the low amounts can be degraded easily by RNAses. 
Very high background concentrations had a more significant suppression effect in RT 
synthesis rate and in later real-time PCR efficiency.
4  
No matter how accurately the concentration of the standard material is known, the final result 
is always reported relatively compared to a defined unit of interest, e.g., copies per defined 
ng of total RNA, copies per genome (6.4 pg DNA), copies per cell, copies per gram of tissue, 
copies per ml blood, etc. If absolute changes in copy number are important, then the 
denominator still must be shown to be absolute stable across the comparison. This accuracy 
may only be needed in screening experiments (amount of microorganism in food), to 
measure the percentage of GMO (genetic modified organism) in food, to measure the viral 
load or bacterial load in immunology and microbiology. The quality of your gene 
quantification data cannot be better than the quality of the denominator. Any variation in the A-Z of quantitative PCR (Editor:  SA Bustin)                                     Chapter3. Quantification strategies in real-time PCR    95 
denominator will obscure real changes, produce artificial changes, and wrong quantification 
results. Careful use of controls is critical to demonstrate that your choice of denominator was 
a wise one.
49 Under certain circumstances, absolute quantification models can also be 
normalized using suitable and unregulated references or housekeeping genes (see Section 
3.4 Normalization).  
 
 
3.2.6.2. Relative  Quantification 
Relative quantification determines the changes in steady-state mRNA levels of a gene 
across multiple samples and expresses it relative to the levels of an internal control RNA. 
This reference gene is often a housekeeping gene and can be co-amplified in the same tube 
in a multiplex assay or can be amplified in a separate tube.
56,59 Therefore, relative 
quantification does not require standards with known concentrations and the reference can 
be any transcript, as long as its sequence is known.
29 Relative quantification is based on the 
expression levels of a target gene versus a reference gene and in many experiments is 
adequate for investigating physiological changes in gene expression levels. To calculate the 
expression of a target gene in relation to an adequate reference gene various mathematical 
models are established. Calculations are based on the comparison of the distinct cycle 
determined by various methods, e.g., crossing points (CP) and threshold values (Ct) at a 
constant level of fluorescence; or CP acquisition according to established mathematic 
algorithm.
50,51,69 To date, several mathematical models that determine the relative expression 
ratio have been developed. Two types of relative quantification models are available and 
published: (1) without efficiency correction (see Eqs. 3.1-3.2).
11,61,70   
R= 2
-[   ∆CP sample - ∆CP control]
(3.1)
=   2
- ∆∆CP
R
(3.2) 
and (2) with kinetic PCR efficiency correction (Eqs.3.3-3.6).
50,51,68,69,74-78 Further, the available 
models allow for the determination of single transcription difference between one control and A-Z of quantitative PCR (Editor:  SA Bustin)                                     Chapter3. Quantification strategies in real-time PCR    96 
one sample, assayed in triplicates (n = 1/3), e.g., LightCycler Relative Quantification 
Software
65 or Q-Gene
79 or for a group-wise comparison for more samples (up to 100), e.g., 
REST and REST-XL.
69 The relative expression ratio of a target gene is computed, based on 
its real-time PCR efficiencies (E) or a static efficiency of 2, and the crossing point (CP) 
difference (∆) of one unknown sample (treatment) versus one control (∆CP  control - treatment). 
Using REST and REST-XL, the relative calculation procedure is based on the MEAN CP of 
the experimental groups (Eq. 3.4)   http://REST.gene-quantification.info/   
( Etarget)
∆CPtarget ( control – sample )
ratio =
( Eref)
∆CPref ( control – sample )
(3.3)
( Etarget)
∆CPtarget ( MEAN control – MEAN sample )
( Eref)
∆CPref ( MEAN control – MEAN sample ) ratio =
(3.4) 
In these models the target-gene expression is normalized by a non-regulated reference gene 
expression, e.g., derived from classical and frequently described housekeeping genes.
11,39-
41,43 The crucial problem in this relative approach is that the most common reference-gene 
transcripts from so-called housekeeping genes, whose mRNA expression can be regulated 
and whose levels vary significantly with treatment or between individuals.
43,80-83 However, 
relative quantification can generate useful and biologically relevant information when used 
appropriately. 
( Eref)
CPsample
( Etarget)
CPsample÷ ratio =
( Eref)
CPcalibrator
( Etarget)
CPcalibrator
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conc(target sample) / conc(ref sample) * MF
ratio =
conc(target cal.) / conc(ref cal.) * CF
(3.6) 
 
 
3.2.7. Advantages and Disadvantages of External Standards 
External standard quantification is the method of choice for the nucleic acid quantification, 
independent of any hardware platform used. The specificity, sensitivity, linearity, and 
reproducibility allow for the absolute and accurate quantification of molecules even in tissues 
with low mRNA abundance (< 100 molecules/reaction setup) and detection down to a few 
molecules (< 10 molecules/reaction setup).
4,12,56,71 The dynamic range of an optimal validated 
and optimized external standardized real-time RT-PCR assay can accurately detect target 
mRNA up to nine orders of magnitude or a billion-fold range with high assay linearity 
(correlation coefficient; r > 0.99).
4,12,49,56,84 In general, a mean intra-assay variation of 10-20% 
and a mean inter-assay variation of 15-30% on molecule basis (maximal 2-4% variability on 
CP basis, respectively) is realistic over the wide dynamic range.
6,12,47,56,71,85 At high (> 10
7) 
and low (< 10
3) template copy input levels the assay variability is higher than in the range 
between the two.
4,47,49 At very low copy numbers, under 20 copies per tube, the random 
variation due to sampling error (Poisson's error law) becomes significant.
49,76  
A recDNA calibration curve model can quantify precisely only cDNA molecules derived from 
the RT step; it says nothing about the conversion to cDNA of the mRNA molecules present in 
the native total RNA sample. Variability in cDNA synthesis efficiency during reverse 
transcription must be always kept in mind. Therefore, a recRNA calibration curve model has 
the advantage that both RNA templates undergo parallel RT and real-time PCR steps. 
However, a direct comparison suggests that the recDNA quantification model shows higher 
sensitivity, exhibits a larger quantification range, has a higher reproducibility, and is more 
stable than the recRNA model.
4 Furthermore, recDNA external calibration curves exhibit 
lower variation (intra-assay variation < 0.7%; inter-assay variation < 2.6% on CP basis) than 
the recRNA model (< 2.7% and < 4.5%, respectively). Clearly, the RT step has a profound 
affect on the overall result obtained from an RT-PCR assay and more thorough consideration 
of RT efficiency is needed.  
The main disadvantage of external standards is the lack of internal control for RT and PCR 
inhibitors. All quantitative PCR methods assume that the target and the sample amplify with 
similar efficiency.
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may contain substances that significantly reduce the efficiency of the PCR reaction in the 
unknown samples. As discussed, sporadic RT and PCR inhibitors or different RNA/cDNA 
distributions can occur. A dilution series can be run on the unknown samples and the 
inhibitory factors can often be diluted out, causing a non-linear standard curve.
49,58,68,69  
Real-time assays using SYBR Green I can easily reveal the presence of primer dimers, 
which are the product of nonspecific annealing and primer elongation events.
58 These events 
take place as soon as PCR reagents are combined. During PCR, formation of primer dimers 
competes with formation of specific PCR product, leading to reduced amplification efficiency 
and a less successful specific RT-PCR product.
86 To distinguish primer dimers from the 
specific amplicon a melting curve analysis can be performed in all available quantification 
software.
61,64,65 The pure and homogeneous RT-PCR products produce a single, sharply 
defined melting curve with a narrow peak. In contrast, the primer dimers melt at relatively low 
temperatures and have broader peaks.
87 To avoid primer dimer formation, an intensive 
primer optimization is needed, by testing multiple primer pair using cross-wise 
combinations.
51 Multiple optimization strategies have been developed and are published.
88-90 
The easiest and most effective way to get rid of any dimer structures, at least during the 
quantification procedure, is to add an additional 4
th segment to the classical three-segmented 
PCR procedure: 1
st segment with denaturation at 95°C; 2
nd segment with primer annealing at 
55-65°C; 3
rd segment with elongation at 72°C; and 4
th segment with fluorescence acquisition 
at elevated temperatures.
47,56,91 The fluorescence acquisition in 4
th segment is performed 
mainly in the range of 80-87°C, eliminates the non-specific fluorescence signals derived by 
primer dimers or unspecific minor products, and ensures accurate quantification of the 
desired product. High temperature quantification keeps the background fluorescence and the 
"no-template control" fluorescence under 2-3% of maximal fluorescence at plateau.
47,56  
“Do we need to run a calibration curve in each run?”
49 and “Do we need a calibration curve at 
all?”
64,65,85 are frequently posed questions, together with “What about the reproducibility 
between the runs?” 
(http://www.idahotec.com/lightcycler_u/lectures/quantification_on_lc.htm). Repeated runs of 
the same standard curve give minor variations of a 2-3% in the slope (real-time PCR 
efficiency) and about 10% in the intercept of calibration curve. Since the variation in the 
standard curve correlates with variation in the unknowns, a detection of a 2-fold difference 
over a wide range of target concentrations is possible.
49 The slope of the calibration curve is 
more reproducible than the intercept, hence only a single standard point will be required to 
“re-register” a previously performed calibration curve level for the new unknowns. The curve 
can be imported into any run, as done in the LightCycler software.
64 Never changing 
variations and 100% reproducibility are the big advantages of such a calibration curve import, 
but there are also disadvantages as variations of reagents, primers, and probe (sequence 
alterations and fluorescence intensity), day-to-day or sample-to-sample variations will not be A-Z of quantitative PCR (Editor:  SA Bustin)                                     Chapter3. Quantification strategies in real-time PCR    99 
covered in this "copy-and-paste" approach. Since these affect PCR efficiency, such an 
approach can introduce significant errors into the quantification. 
 
 
3.2.8. Real-Time PCR Amplification Efficiency 
Individual samples generate different and individual fluorescence histories in kinetic RT-PCR. 
The shapes of amplification curves differ in the steepness of any fluorescence increase and 
in the absolute fluorescence levels at plateau depending on background fluorescence levels. 
The PCR efficiency has a major impact on the fluorescence history and the accuracy of the 
calculated expression result and is critically influenced by PCR reaction components. 
Efficiency evaluation is an essential marker in real-time gene quantification procedure.
45,49-
51,77,78 Constant amplification efficiency in all compared samples is one important criterion for 
reliable comparison between samples. This becomes crucially important when analyzing the 
relationship between an unknown sequence and a standard sequence, which is performed in 
all relative quantification models. In experimental designs employing standardization with 
housekeeping genes, the demand for invariable amplification efficiency between target and 
standard is often ignored, despite the fact that corrections have been suggested.
68,69,77,78 A 
correction for efficiency, as performed in efficiency corrected mathematical models (Eq. 3.3 – 
3.6), is strongly recommended and results in a more reliable estimation of the "real 
expression ratio" compared to NO-efficiency correction. Small efficiency differences between 
target and reference gene generate false expression ratio, and the researcher over- or 
under-estimates the "real" initial mRNA amount. Difference in PCR efficiency (∆E) of 3% (∆E 
= 0.03) between target gene and reference gene generate a falsely calculated differences in 
expression ratio of 47% in case of Etarget < Eref and 209% in case of Etarget > Eref after 25 
performed cycles. This gap will increase dramatically by higher efficiency differences ∆E = 
0.05 (28% and 338%, respectively) and ∆E = 0.10 (7.2% and 1083%, respectively) and 
higher cycle number performed.
49,69 Therefore efficiency corrected quantification corrections 
should be included in the automation and calculation procedure in relative quantification 
models.  
The assessment of the exact amplification efficiencies of target and reference genes must be 
carried out before any calculation of the normalized gene expression is done. LightCycler 
Relative Expression Software,
65 Q-Gene,
79 REST, and REST-XL  software applications
69 
allow the evaluation of amplification efficiency plots. A separate determination of real-time 
PCR efficiency in triplets for every tissue and each performed transcript is necessary.
64,68,69,79 
Different tissues exhibit different PCR efficiencies, caused by RT inhibitors, PCR inhibitors, 
and by variations in the total RNA fraction pattern extracted. Several methods are described 
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A)  Efficiency calculation from the slopes of the calibration curve according to the equation: 
E = 10 
[–1/slope], as described earlier.
5,49,61 Determination of efficiency should be 
evaluated in a pool of all starting RNAs to accumulate all possible "negative impacts" 
on kinetic PCR efficiency. Usually, real-time PCR efficiency vary with high linearity (r > 
0.989) from E = 1.60 to maximal values up to E = 2.10 for cDNA input ranges from a 
few pg to 75 ng cDNA input.
12,56,69,71 Typically, the relationship between CP and the 
logarithm of the starting copy number of the target sequence should remain linear for 
up to five orders of magnitude in the calibration curve as well as in the native sample 
RNA.
79 This calculation method results, in some cases, in efficiencies higher than (E > 
2.0), which is practically impossible in the PCR amplification theory. But as shown in 
given results they are highly reproducible and constant within one transcript and 
tissue.
68,71 This probably indicates that this efficiency calculation method is not optimal 
and overestimates the "real efficiency."  
B)  Efficiency calculation from the fluorescence increase in 3
rd linear phase of each 
logarithmic fluorescence history plot. The investigator has to decide which cycle 
number to include in the analysis and plot a linear regression (similarly to the Fit Point 
Method regression) where the slope of the regression line represents the PCR 
efficiency. Here efficiencies between E = 1.35 and E = 1.60 are realistic and differ 
dramatically from the results above.
47,92 This efficiency calculation method might 
underestimate the "real efficiency," because data evaluation is made in linear phase 
near the plateau where reaction trend to get restrictive.
46  
C)  Efficiency calculation on the basis of all fluorescence data points (starting at cycle 1
st 
up to the last cycle), according to a sigmoidal or logistic curve fit model. The advantage 
of such model is that all data points will be included in the calculation process. No 
background subtraction is necessary.
45,50,51,77,78 Slope value is "nearly" identical to 
method B and only measured at the point of inflexion at absolute maximum 
fluorescence increase (1.35 < E < 1.60). But the derived slope parameters generated 
by the sigmoidal or logistic models are not directly comparable with the "real PCR 
efficiency." This method is easy to perform and a good estimator for the maximum 
curve slope with high correlation coefficient (r > 0.99) and level of significance (p < 
0.001).
45,50,51,77,78  
D)  Efficiency calculation from the fluorescence increase only in the 2
nd real exponential 
phase, according to a polynomial curve fit, as described earlier Yn = Y0 (E)
n, where Yn 
is fluorescence acquired at cycle n, and Y0 initial fluorescence, so-called ground 
fluorescence.
45,74,92-94 This phase around the “Second Derivate Maximum” exhibit a real 
exponential amplification behavior.
45 Here in the exponential part of the PCR reaction, 
kinetic is still under "full power" with no restrictions.
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performed on each reaction kinetic plot and the amplification efficiency can be 
determined exactly. They range from E = 1.75 to E = 1.90, hence are between the 
other methods. 
 
Which efficiency calculation method is "the right one" and which one shows the realistic real-
time PCR kinetic and thereby is highly reproducible, has to be evaluated in further 
experiments. 
 
 
3.2.9. Data Evaluation 
The next marker in gene quantification using real-time RT-PCR is the data evaluation. The 
calculation unit in real-time PCR is a sample specific and characteristic crossing points (CP). 
For CP determination various fluorescence acquisition methodologies are possible. The “Fit 
Point Method” and “Threshold Cycle Method” measure the CP at a constant fluorescence 
level.
5,7,61,64,74 These constant threshold methods assume that all samples have the same 
cDNA concentration at the threshold fluorescence. Measuring the level of background 
fluorescence can be a challenge in real-time PCR reactions with significant background 
fluorescence variations caused by drift-ups and drift-downs over the course of the reaction. 
Averaging over a drifting background will give an overestimation of variance and thus 
increase the threshold level.
61,49 The threshold level can be calculated by fitting the 
intersecting line upon the ten-times value of ground fluorescence standard deviation. This 
acquisition mode can be easily automated and is very robust.
61 In the “Fit Point Method” the 
user has discard the uninformative background points, exclude the plateau values by 
entering the number of log-linear points, and then fits a log-line to the linear portion of the 
amplification curves. These log lines are extrapolated back to a common threshold line and 
the intersection of the two lines provides the CP value. The strength of this method is that it 
is extremely robust. The weakness is that it is not easily automated and so requires a lot of 
user interaction.
49,64 “Fit Point Method” or  “Threshold Cycle Method” can be used on all 
available platforms with different evaluation of background variability. 
The problems of defining a constant background for all samples within one run, sample-to-
sample differences in variance and absolute fluorescence values lead to develop a new 
acquisition modus according to mathematical algorithms. In the LightCycler software the 
“Second Derivative Maximum Method” is performed where CP is automatically identified and 
measured at the maximum acceleration of fluorescence.
49,64 The kinetic fluorescence 
histories of individual curves are different. They show individual background variability (1
st 
phase), exponential and linear growth of fluorescence (2
nd and 3
rd phase), and finally 
reaction-specific plateau values (4
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fluorescence history over various cycles is obviously not a smooth and easy function. The 
mathematical algorithm on which the “Second Derivative Maximum Method” in Roche 
Molecular Biochemicals software is based is unpublished. But it is possible to fit sigmoidal 
and polynomial curve models
45,50,51,77,78 with high significance (p < 0.001) and coefficient of 
correlation (r > 0.99), which can be differentiated, and the second-derivate maximum can be 
estimated.
45,50,51 This increase in the rate of fluorescence increase, or better called the 
acceleration of the fluorescence signal, slows down at the beginning of the 3
rd linear phase. 
Therefore the cycle where the second derivative is at its maximum is always between 2
nd 
exponential and 3
rd linear phase.
45  
 
 
3.3.  Automation of the Quantification Procedure 
Automation of quantification with any kind of calibration curve using “Fit Point 
Method,”“Threshold Cycle Method” or “Second Derivative Maximum Method” is fully 
supported by the software supplied with the real-time instruments. The investigator has to 
input his individual settings, e.g., threshold level and noise band, import an existing standard 
curve, and then click for calculation of the CPs and the corresponding concentrations. 
However, although relative expression is performed by researchers according to several 
established mathematical models (Eqs. 3.1-3.6),
61,68-70,75,79 up to now relative quantification 
software has been commercially available only from Roche Molecular Biochemicals 
“LightCycler Relative Quantification Software” (http://www.lightcycler-
online.com/lc_sys/soft_ind.htm#quant). The software allows for a comparison of maximal 
triplets (n = 3) of a target versus a calibrator gene, both corrected via a reference-gene 
expression and calculates on the basis of the median of the performed triplets. Real-time 
PCR efficiency correction is possible within the software and calculated from the calibration 
curve slope, according to the established equation E = 10 
[–1/slope], ranging from E = 1.0 
(minimum value) to E = 2.0 (theoretical maximum and efficiency optimum). A given correction 
factor (CF) and a multiplication factor (MF), which are provided in the product specific 
applications (Eq. 3.6) by Roche Molecular Biochemicals, have to be attended in the equation 
calculation process.
65  
Importantly, until recently it was not possible to perform a reliable group-wise calculation of 
the relative expression ratios and a subsequent statistical comparison of the results by a 
statistical test with more than three repeats or more than three samples. This has changed 
when new software tools were established (e.g. REST and REST-XL), both Excel®-based 
and programmed in Visual Basic for Applications.
68,69 Both compare two treatment groups, 
with multiple data points in sample group versus control group, and calculate the relative 
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calculated in REST-XL. The mathematical model used is published;
69 it is based on the 
MEAN crossing point deviation between sample and control group of up to four target genes, 
normalized by the MEAN crossing point deviation of a reference gene (Eq. 3.4). 
Normalization via endogenous control can be performed according to the users demand, but 
it is recommended to compensate intra- and inter-RT-PCR variations.
68,69,95 Therefore the 
requirement for high reproducibility of RT and RT efficiency is not "that important" anymore. 
cDNA input concentration variation of ±3-fold was evaluated to mimic these huge RT 
variations and resulted in no significant changes of relative expression ratio.
69 Specific 
amplification efficiencies of four target-gene genes can be estimated and included in the 
correction of the quantification ratio. If no real-time PCR efficiency assessment is performed, 
REST assumes an optimal efficiency of E = 2.0. The big advantage of the software tool is the 
subsequent statistical test. REST tests the group differences for significance with a newly 
developed randomization test - Pair-Wise Fixed Reallocation Randomization Test©. Variation 
depends only on CP variation of the investigated transcripts and remains stable between 3% 
and 12%.
69  
Nevertheless, successful application of real-time RT-PCR and REST depends on a clear 
understanding of the practical problems. Therefore a coherent experimental design, 
application, and validation of the individual real-time RT-PCR assay remains essential for 
accurate and fully quantitative measurement of mRNA transcripts  http://REST.gene-
quantification.info/   
Recently a second software tool, named Q-Gene, was developed.
79 Q-Gene manages and 
expedites the planning, performance, and evaluation of quantitative real-time PCR 
experiments, as well as the mathematical and statistical analysis, storage, and graphical 
presentation of the data. An efficiency correction is possible. The Q-Gene software 
application is a tool to cope with complex quantitative real-time PCR experiments at a high-
throughput scale (96-well and 384-well format) and considerably expedites and rationalizes 
the experimental setup, data analysis, and data management while ensuring highest 
reproducibility (http://www.biotechniques.com/softlib/qgene.html). 
 
 
3.4. Normalization 
Data normalization in real-time RT-PCR is a further major marker in gene quantification 
analysis. The reliability of any relative RT-PCR experiment can be improved by including an 
invariant endogenous control in the assay to correct for sample-to-sample variations in RT-
PCR efficiency and errors in sample quantification. A biologically meaningful reporting of 
target mRNA copy numbers requires accurate and relevant normalization to some standard 
and is strongly recommended in kinetic RT-PCR.
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quantitative expression data cannot be better than the quality of the normalizer itself. Any 
variation in the normalizer will obscure real changes and produce artifactual changes.
28,29 
Real-time RT-PCR-specific errors in the quantification of mRNA transcripts are easily 
compounded with any variation in the amount of starting material between the samples, e.g., 
caused by sample-to-sample variation, variation in RNA integrity, RT efficiency differences, 
and cDNA sample loading variation.
15,31,95 This is especially relevant when the samples have 
been obtained from different individuals, different tissues, and different time courses and will 
result in the misinterpretation of the derived expression profile of the target genes. Therefore, 
normalization of target-gene expression levels must be performed to compensate intra- and 
inter-kinetic RT-PCR variations (sample-to-sample and run-to-run variations). 
Data normalization can be carried out against an endogenous unregulated reference gene 
transcript or against total cellular DNA or RNA content (molecules/g total DNA/RNA and 
concentrations/g total DNA/RNA). Normalization according the total cellular RNA content is 
increasingly used, but little is known about the total RNA content of cells or even about the 
mRNA concentrations. The content per cell or per gram tissue may vary in different tissues in 
vivo, in cell culture (in vitro), between individuals and under different experimental conditions. 
Nevertheless, it has been shown that normalization to total cellular RNA is the least 
unreliable method.
3,28,29 It requires an accurate quantification of the isolated total RNA or 
mRNA fraction by optical density at 260 nm (OD260), Agilent Bioanalyser 2100, or RiboGreen 
RNA Quantification Kit. Alternatively the rRNA content has been proposed as an optimal and 
stable basis for normalization, despite reservations concerning its expression levels, 
transcription by a different RNA polymerase, and possible imbalances in rRNA and mRNA 
fractions between different samples.
29,42,80,96,97   
To normalize the absolute quantification according to a single reference gene, a second set 
of kinetic PCR reactions has to be performed for the invariant endogenous control on all 
experimental samples and the relative abundance values are calculated for internal control 
as well as for the target gene. For each target gene sample, the relative abundance value 
obtained is divided by the value derived from the control sequence in the corresponding 
target gene. The normalized values for different samples can then be directly compared. The 
sets of CPs for the reference gene can be easily imported into the REST software 
application, according to the given equations (Eqs. 3.3-3.4). The calculation process 
considers them and allows for a normalization of the target genes with the reference 
gene.
64,68,69,79 Additionally, it will show whether normalization via the chosen reference is 
useful by showing the factor of regulation and level of significance as result of the 
randomization test. The investigators can decide if the reference is suitable in this 
experimental trial or not. 
Here a central question arises: “What is the appropriate reference gene for an experimental 
treatment and investigated tissue?”
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GAPDH, albumin, actins, tubulins, cyclophilin, microglobulins, 18S rRNA or 28S rRNA
27,39-
42,50may be suitable for reference genes, since they are present in all nucleated cell types 
and are necessary for basic cell survival. The mRNA synthesis of housekeeping genes is 
considered to be stable in various tissues, even under experimental treatments.
39-41,50 
However, numerous treatments and studies have already shown that the mentioned 
housekeeping genes are regulated and vary under experimental conditions.
42,43,80-83,99 It 
remains up to the individual investigator to choose a reference gene that is best for reliable 
normalization in their particular experimental setting. In addition, the endogenous control 
should be expressed at roughly the same CP level as the target gene.
3,28 At the same CP 
level, reference and target experience the same condition and real-time RT-PCR kinetics 
with respect to polymerase activation (heat activation of polymerase), reaction inactivation, 
stochastic relation between target and primer concentration, and reaction end product 
inhibition by the generated RT-PCR product.  
It cannot be emphasized enough that the choice of housekeeping or lineage specific genes 
is critical. For a number of commonly used reference genes processed pseudogenes have 
been shown to exist, e.g.￿-actin or GAPDH.
22-24 These pseudogenes may be responsible for 
specific amplification products in an mRNA-independent fashion and result in specific 
amplification even in the absence of intact mRNA.
18-21,84 It is vital to develop universal, 
artificial, stable, internal standard materials that can be added prior to the RNA preparation to 
monitor the efficiency of RT as well as the kinetic PCR respectively.
29 Usually more than one 
housekeeping genes should be tested in a multiple pair wise correlation analysis and its 
behavior summarized to a housekeeping gene index called BestKeeper© 
105. According to 
this  BestKeeper© index, which is based on the weighted expression of at least three 
housekeeping genes, a more reliable basis of normalization in relative quantification can be 
postulated.
69,100,101  http://www.gene-quantification.de/bestkeeper.html   
There is increasing appreciation of these aspects of quantitative RT-PCR and recently a 
software tool was established for the evaluation of housekeeping genes expression levels. 
GeNorm
27 allows for an accurate normalization of real-time quantitative RT-PCR data by 
geometric averaging of multiple internal control genes 
(http://allserv.rug.ac.be/~jvdesomp/genorm/). The geNorm VBA applet for Microsoft Excel 
determines the most stable housekeeping genes from a set of ten tested genes in a given 
cDNA sample panel, and calculates a gene expression normalization factor for each tissue 
sample based on the geometric mean of a user defined number of housekeeping genes. The 
normalization strategy used in geNorm is a prerequisite for accurate kinetic RT-PCR 
expression profiling, which opens up the possibility of studying the biological relevance of 
small expression differences.
27  
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3.5. Statistical  Comparison 
Bio-informatics and bio-statistics on real-time RT-PCR experiment data is a new subject and 
a new challenge in gene quantification analysis. This is because the coordination of the 
experiments and the efficient management of the collected data has become an additional 
major hurdle for kinetic RT-PCR experiments. The main challenge remains the evaluation 
and the mathematical and statistical analysis of the enormous amount of data gained by this 
technology, as these functions are not included in the software provided by the 
manufacturers of the detection systems.
79 Normally the statistical data analysis in gene 
quantification, independent of block, competitive or real-time RT-PCR experiments, are all 
performed on the basis of classical standard parametric tests, such as analysis of variance or 
t-tests.
102 Parametric tests depend on assumptions, such as normality of distributions, whose 
validity is unclear. In absolute or relative quantification analysis, where the quantities of 
interest are derived from ratios and variances can be high, normal distributions might not be 
expected, and it is unclear how a parametric test could best be constructed.
69  
Only two free available software packages support statistical analysis of expression results: 
Q-Gene
79 and REST.
69 The Q-Gene Statistics Add-In is a collection of several VBA programs 
for the rapid and menu-guided performance of frequently used parametric and nonparametric 
statistical tests. To assess the level of significance between any two groups expression 
values, it is possible to perform a paired or an unpaired Student’s test, a Mann-Whitney U-
test, or Wilcoxon signed-rank test.
102 In addition, the Pearson’s correlation analysis can be 
applied between two matched groups of expression values. Furthermore, all statistical 
programs calculate the mean values of both groups analyzed and their difference in 
percent.
79  
Permutation or randomization tests are a useful alternative to more standard parametric tests 
for analyzing experimental data.
103,104 They have the advantage of making no distributional 
assumptions about the data, while remaining as powerful as conventional tests. 
Randomization tests are based on one we know to be true: that treatments were randomly 
allocated.
103,104 The randomization test is conducted as follows: A statistical test is based on 
the probability of an effect as large as that observed occurring under the null hypothesis of 
no treatment effect. If this hypothesis is true, the values in one treatment group were just as 
likely to have occurred in the other group. The randomization test repeatedly and randomly 
reallocates the observed values to the two groups and notes the apparent effect (expression 
ratio in REST) each time. The proportion of these effects, which are as great as that actually 
observed in the experiment gives us the p-value of the test 
(http://www.bioss.ac.uk/smart/unix/mrandt/slides/frames.htm).  
The REST software package makes full use of the advantages of a randomization test.
69 In 
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CP values for reference and target genes are jointly reallocated to control and sample groups 
(= pair-wise fixed reallocation), and the expression ratios are calculated on the basis of the 
mean values. In practice, it is impractical to examine all possible allocations of data to 
treatment groups, and a random sample is drawn. If 2,000 or more samples are taken, a 
good estimate of p-value (standard error < 0.005 at p = 0.05) is obtained.
103,104 
Randomization tests with a pair-wise reallocation are seen as the most appropriate approach 
for this type of application. They are more flexible than non-parametric tests based on ranks 
(Mann-Whitney, Kruskal-Wallis, etc.) and do not suffer a reduction in power relative to 
parametric tests (t-tests, ANOVA, etc.). They can be slightly conservative (i.e., type I error 
rates lower than the stated significance level) due to acceptance of randomizations with 
group differences identical to that observed, but this mainly occurs when used with discrete 
data.
103,104  
 
 
3.6. Conclusion 
The recent advances in gene quantification strategies, fluorescence chemistries, and 
instrumentations have led to the development of various assays whereby mRNA transcripts 
can be quantified precisely in very short time. The benefits in terms of increased sensitivity, 
reduced variability, reduced risk of contamination, increased throughput by automation, and 
meaningful data interpretation are obvious. If done properly, kinetic RT-PCR is the most 
powerful method for quantifying cellular mRNA levels. The quantification strategy used 
should be designed according to the researchers demand, but must be highly optimized and 
precisely validated. In the future, there is a need for greater standardization of the applied 
assays to make the expression results comparable between runs, between real-time RT-
PCR platforms, and between different laboratories worldwide.  
Sharing any technical and practical information for sample preparation, assay design, 
standard materials, and data management will help to improve gene quantification analysis. 
Therefore various information platforms and discussion forums are available on the internet 
(summarized under  http://infoportal.gene-quantification.info/ ). A-Z of quantitative PCR (Editor:  SA Bustin)                                     Chapter3. Quantification strategies in real-time PCR    108 
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